Description
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Cas No. | 1096708-71-2 |
|---|---|
| Purity | ≥98% |
| Formula | C17H12Cl2F3N7O2S |
| Formula Wt. | 506.30 |
| IUPAC Name | 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5- chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide |
| Solubility | DMSO 100 mg/mL (197.51 mM) Ethanol 100 mg/mL (197.51 mM) Water Insoluble |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
http://clinicaltrials.gov/show/NCT01425008
Endogenous peptide, involved in water/Na+ homeo...
Chaetocin is naturally produced by Chaetomium s...
Pentacyclic triterpene found in various plant s...
HEXIM1 activator.
CDK4/6 inhibitor.
Cannabinoid receptor 2 selective agonist.
Monoterpene; nAChR antagonist.
BHA derivative, antioxidative food and cosmetic...
Macrolide antibiotic; vacuolar H+ ATPase inhibi...
HIV and AIDS
Isoquinoline alkaloid found in a variety of pla...
PAK4 inhibitor.
Glycoside hydroquinone originally found in Berg...
NSAID; COX-1/2 inhibitor.
PKA substrate.
Thienopyridine; P2Y12 antagonist.
Antibiotic
Benzophenanthridine alkaloid; topoisomerase I i...
Pyramido-pyrrolo-quinoxalinedione; CFTR blocker...
Microtubule depolymerization inhibitor.